fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Multiple Myeloma Survivors- Risk Factors Heart Health

Share Button

Therapies for multiple myeloma are extremely effective, with overall response rates approaching 100% with initial therapy.3 In general, treatments are well tolerated but do carry some specific Cardiovascular (CV) -related complications…”

The question is not if chemotherapy regimens for the treatment of multiple myeloma (MM) increase your risk of cardiovascular (CV) complications.  The question is if a multiple myeloma survivor can reduce his/her risks of these CV complications. MM therapies do increase your risk of many different types of CV complications including blood clots, heart failure, etc. What is not well documented is if you, the MM survivor, can reduce or prevent these risks.

I was diagnosed with multiple myeloma at 34. But toxic chemotherapy did cause several long-term and late stage side effects.

What I take from the articled below is not at what age you undergo aggressive chemotherapy and/or radiation. It’s how toxic therapies can have short, long term or late-stage side effects that can disable and eventually kill the cancer patient.  I underwent both anthracycline-based chemotherapy (vincristine) as well as cytoxan aka cyclophosphamide. Both carry a serious risk of heart damage. I underwent both chemotherapies in 1995-97- years before the writing of this blog post. I developed chronic atrial fibrillation in the fall of 2010.

Though I developed a series of CV complications from my many different MM therapies, I have managed to remain in complete remission from my MM and I have managed my DVTs (in both legs), managed my afib and managed my chemotherapy-induced cardiomyopathy (CIC).

Yes, I should have initiated several evidence-based, non-toxic therapies before I developed all my CV complication but then again, I didn’t know what my risks were. This post documents these risks. Please consider taking action to reduce your risks of CV-related complications.

I am both a MM survivor and MM coach. I have spent hours researching evidence-based non-conventional therapy shown to manage and or heal the damage done by my conventional toxic therapies.

To learn more about those therapies to manage side effects of conventional oncologic therapies, scroll down the page, post a question or comment and I will reply ASAP.

thank you,

David Emerson

  • MM Survivor
  • MM Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Cardiac Considerations for Modern Multiple Myeloma Therapies

Myeloma Therapies With Known CV Risks-

Therapies for multiple myeloma are extremely effective, with overall response rates approaching 100% with initial therapy.3 In general, treatments are well tolerated but do carry some specific CV-related complications…”

Cardiovascular Complications of Novel Multiple Myeloma Treatments

“Overview-MM is a plasma cell malignancy characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment, monoclonal protein in the blood or urine, and associated organ dysfunction...1

Thrombosis and MM- Cancer is associated with increased risk of venous thromboembolic events (VTEs).4

Increased VTE Risk With IMiDs-The increased VTE risk associated with IMiDs came to attention in 2001, when 2 separate phase 2 clinical trials using thalidomide-based chemotherapy reported a high incidence of VTEs: 7% and 27%.11…

 

 

Leave a Comment:

2 comments
Add Your Reply